This inventor holds 1 USPTO granted patent. Top assignees: 2692372 Ontario, Inc., Dunad Therapeutics Ltd.. Active years: 2026.
Company Filing History:
1 out of 1 
1 out of 1 Years Active: 2026
Title: Geordon A Frere: Innovator in Pharmaceutical Chemistry
Introduction: Geordon A Frere is a notable inventor based in Drayton, California. He has made significant contributions to the field of pharmaceutical chemistry, particularly through his innovative work on benzenesulfonamide derivatives. His research focuses on the development of compounds that can disrupt proteins and polypeptides, which are crucial in the treatment of various diseases.
Latest Patents: Geordon A Frere holds a patent for "Benzenesulfonamide derivatives and uses thereof." This patent includes benzenesulfonamide derivatives characterized by a specific formula, along with pharmaceutical compositions that incorporate these compounds. The methods described in the patent aim to utilize these compounds for disrupting protein and polypeptide functions, thereby addressing diseases linked to these biological molecules.
Career Highlights: Throughout his career, Geordon has worked with various companies, including 2692372 Ontario, Inc. and Dunad Therapeutics Ltd. His expertise in pharmaceutical chemistry has allowed him to contribute to advancements in drug development and therapeutic applications.
Collaborations: Geordon has collaborated with professionals such as Sana Rasheed and Erica J Quilates. These partnerships have enhanced his research and development efforts in the pharmaceutical sector.
Conclusion: Geordon A Frere's work exemplifies the intersection of innovation and pharmaceutical science. His contributions through patents and collaborations continue to impact the field positively.